Log In
BCIQ
Print this Print this
 

DOTA-SOM, OPS101, pasireotide tetraxetan

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionGallium-68-labeled radioactive agent for PET imaging agonizing somatostatin receptors 1, 2, 3 and 5
Molecular Target Somatostatin receptor
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose cancer; Diagnose gastro-entero-pancreatic neuroendocrine tumors
Regulatory Designation EU - Orphan Drug (Diagnose gastro-entero-pancreatic neuroendocrine tumors)
PartnerIpsen Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today